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Abstract 
Background We aimed to identify a brief screening measure for detection of cognitive deficit in 
children treated for cerebellar tumors that would be useful in clinical practice.  
Methods A sample of 72 children aged 8-14 years and within three years post-diagnosis for 
standard risk medulloblastoma (n=37) or low grade cerebellar astrocytoma (n=35) and 38 in a 
non-tumor group were assessed using teacher-, parent-, and child-report of the Behavior Rating 
Inventory of Executive Function (BRIEF), Strengths and Difficulties Questionnaire (SDQ), and 
Pediatric Quality of Life Inventory (PedsQL). The accuracy of these scores as a screen for a full 
scale Intelligence Quotient (FSIQ) <80 on the Wechsler Intelligence Scale for Children 
(WISC®-IV UK) was assessed using their receiver operating characteristic (ROC) curves.   
Results The questionnaires with the highest areas under the ROC curves were the child- and 
parent-report PedsQL and the teacher-report BRIEF and SDQ. At optimal cut-off scores, their 
sensitivities (95% CIs) to cases of FSIQ<80 were 84 (60-96)%, 65 (41-84)%, 79 (54-93)%, and 
84 (60-96)% and their specificities (95% CIs) were 79 (68-86)%, 87 (77-93)%, 77 (66-86)%, and 
71 (64-84)% respectively. All cases of FSIQ<80 screened positive on either teacher-report SDQ 
or self-report PedsQL.  
Conclusions The PedsQL child- and parent-report and the teacher-report BRIEF and SDQ have 
moderately good accuracy to discriminate between children with and without a FSIQ<80. The 
PedsQL could be used in a clinical setting, and the BRIEF and SDQ in an educational setting, to 
screen for cases with FSIQ<80 in children treated for brain tumors.   
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Introduction 
Brain tumors are second in incidence to leukemia among neoplasms of childhood and constitute 
23% of all tumors that develop before the age of 15.1 Actuarial 5-year survival for all CNS 
tumors combined was 72-75% among those diagnosed in the UK during 2001-20102 and 72% 
(95% CI 71-73%) in the SEER-18 cancer registries in the USA during 1995-2010.3  
About half of long-term survivors of childhood brain tumors experience significant 
neurocognitive impairment4,5 attributed to the tumor itself, hydrocephalus, neurosurgery,6 
adjuvant radiotherapy,7 or radiotherapy and chemotherapy in combination.8 They achieve 
significantly lower educational attainment than the general population9 and suffer long term 
socio-economic and work place disadvantage.10,11 There is international agreement among 
experts that cognitive and psychosocial deficits affect health-related quality of life (HRQoL) 
among child and adolescent survivors of cancer and monitoring of them should be a priority.12 
To address these issues, there is a need for early and continuing systematic assessment of these 
children to identify the need to expedite the implementation of clinical psychology and other 
services that would enable timely rehabilitation9,13-15 to improve their life chances.  
However, systematic assessment is not always achieved in practice,9,13,16,17 even though 
guidelines advocate such access for all families,17,18 due to limited access to Clinical Psychology 
services that might provide this service.16,17 Prior attempts to screen specifically for cognitive 
deficits have used direct assessments requiring face-to-face administration19-22 which is resource 
intensive. They typically need to be executed by a trained assessor19,20 or psychologist21,22 in a 
designated quiet room in a hospital setting and the additional time needed may prolong the 
hospital visit for the patient by up to 75 minutes.21 Alternatively screening for cognitive deficit 
using brief, accurate, psychometrically robust self-report measures in a clinical setting, without 
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initially the need to engage psychological services might achieve this where limited resources 
preclude face-to-face psychometric assessments. Those falling above or below specified cut off 
scores indicating clinical risk could then undergo a full rehabilitation assessment and be 
considered for intervention. Self-report paper and pencil measures have been successfully 
applied in clinical settings to screen for psychosocial difficulties in children treated for cancer23-
27 and a measure of parent-perceived cognitive function showed good ability to discriminate 
between childhood cancer survivors with and without a brain tumor.28     
We found that cognition and emotion accounted for more than half of the variance in 
HRQoL scores in a representative sample of children treated for cerebellar tumors in the UK15 
and many other studies have found cognitive function to be associated with HRQoL.29-31 Our 
observations15 led us to hypothesize that poor scores on self-report measures of HRQoL, 
executive function, and behavioral function might be sufficiently accurate to be usable not only 
as a screen for deficits in those domains but also as screening tests for the presence of deficits in 
full scale intelligence quotient (FSIQ) in these children. We therefore examine here the accuracy 
of three widely available questionnaire measures with good psychometric properties as screens 
for the detection of children with borderline or greater cognitive deficit, defined as a FSIQ<80.32 
As far as we are aware, this is the first time that the accuracy of self-report measures as screening 
tests for detection of cognitive deficit, as defined by direct psychometric assessment, in children 
with cerebellar tumors.   
Materials and Methods 
Design 
The present study was part of a multi-center prospective longitudinal HRQoL study that was 
undertaken from February 2005 to January 2010. 
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Patients 
We have previously reported the population studied and methods used to obtain both 
questionnaire responses and FSIQ assessments from them in our report on factors predicting 
their HRQoL two years after enrolment in the study.15 Briefly, the participants were children 
aged 8-14 years with either ‘standard risk’ medulloblastoma (i.e. less than 1.5 cm3 residual tumor 
and no evidence of metastatic disease) or low grade cerebellar astrocytoma diagnosed within the 
preceding three years. They were recruited from 11 of the 20 Children’s Cancer and Leukaemia 
Group (CCLG) Children’s Cancer Treatment Centres (CCTCs) in England and Wales over a 
period of 20 months. A non-tumor comparison group was randomly selected from the same year 
groups of the schools attended by children in the tumor groups. The only non-inclusion criteria in 
each group were premorbid disability or inability to communicate in the English language but 
these criteria were not met in any child referred to the study. For the present study of the 
accuracy of questionnaires as screens for concurrent deficits in FSIQ, non-availability of a FSIQ 
score at enrolment to the study was an exclusion criterion that was applied to six of the 110 
participants in the HRQoL study. 
All participating children diagnosed with cerebellar tumor had undergone neurosurgical 
removal of the tumor. Those with medulloblastoma also received adjuvant treatment comprising 
six weeks of daily craniospinal radiotherapy of 23.4 Gy with a boost to 55.8 Gy to the posterior 
fossa and ‘Packer’ regimen chemotherapy (weekly vincristine for eight weeks followed six 
weeks later by eight, six week cycles of chemotherapy consisting of CCNU and cisplatin plus 
vincristine, given weekly for three weeks).33 There were no major deviations from this standard 
treatment. 
Measures 
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We selected the following measures for their good psychometric properties, brevity, and 
applicability to children with brain tumors:15,22,37-39 parent- and teacher-report of the child’s 
executive function in everyday life using the Behavior Rating Inventory of Executive Function 
(BRIEF);34 parent-, teacher- and child-report of the child’s behavior using the Strengths and 
Difficulties Questionnaire (SDQ);35 and parent- and child-report of the child’s HRQoL using the 
Pediatric Quality of Life Inventory (PedsQL).36 15,22,37-39Additionally these seven questionnaires 
are of relatively low cost and widely used in departments of Clinical Psychology. The Wechsler 
Intelligence Scale for Children®-4th UK Edition (WISC®-IV UK)32 was administered as a ‘gold 
standard’ measure of cognitive function. We chose a FSIQ score <80 as the defining threshold 
below which participants were classified as having borderline or greater cognitive deficit, 
according to the WISC®-IV UK manual.32 In a typically developing population, 9% of children 
and young people would be expected to be ‘cases’ (i.e. produce a FSIQ score <80) because this 
is the percentage of a normal distribution expected to fall more than 1.33 SD below the 
population mean and has been used in previous descriptions of cognitive deficits in similar 
populations.40,41 In our sample of children treated for cerebellar tumors, this degree of deficit was 
present in 19/66 (29%) children and identifying them would therefore be a way of identifying 
that proportion of the population in whom cognitive evaluation was most likely to lead to 
interventions to support learning. 
Procedure 
Children fulfilling inclusion criteria were identified from hospital discharge and clinic lists and 
referred to the study center by the treating clinicians. Written informed consent was obtained 
from all participating parents and children. Assessments were undertaken in the family home to 
which questionnaires were sent by post in advance while the WISC was administered at the visit 
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itself. Parents provided information on pre-morbid socio-economic status (SES) classified 
according to the UK Office for National Statistics Socio-economic Classification (ONS 2004). 
Teacher questionnaires were mailed to schools following the home visit. The protocol for this 
study was approved by the UK CCLG. Ethical approval was obtained from the Trent Multi-
Centre Research Ethics Committee, UK. 
Statistical analyses 
All available FSIQ scores, assessed at enrollment into the study, were included in the analyses.  
Screening accuracy was evaluated by plotting receiver operating characteristic (ROC) curves for 
each measure. The ROC curve is an X-Y graph of the accuracy of a screening test for a target 
condition. Sensitivities at all possible screening test threshold scores are plotted on the Y-axis 
against 1–specificity on the X-axis. A 45o diagonal line indicates a screening test operating at a 
chance level of separating true positive from true negative cases of the target condition. 
Youden’s index, the maximum orthogonal distance between the 45o diagonal line and the ROC 
curve, identifies the optimal cut-off score that maximizes the extent to which the test separates 
true positives from true negatives.42 The area under the ROC curve (AUC) gives an overall 
summary of the accuracy of the screening test in identifying the target condition: AUCs of >0.90, 
0.70 to 0.90, and  0.50 to 0.70 are commonly taken to indicate high, moderate, and low accuracy 
respectively while an AUC of 0.50 indicates a chance result.42 Having identified the optimal 
screen threshold score using Youden’s index, the sensitivity (proportion of true positives that 
screen positive), specificity (proportion of true negatives that screen negative), likelihood ratio 
for a screen positive (LR+, the ratio of the probability of a true positive to the probability of a 
false positive) and for a screen negative (LR-, the ratio of the probability of a false negative to 
the probability of a true negative) for that threshold score were calculated for the total sample. A 
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LR+ >7.00 and a LR- <0.30 indicate high screening accuracy.43 Youden’s index, the AUC, 
sensitivity, specificity, LR+, and LR- are independent of the prevalence of a condition whereas 
positive and negative predictive values are not.43 The AUCs, sensitivities and specificities were 
calculated and their 95% confidence intervals used to define the precision of the estimates of the 
accuracy of the screening tests. All analyses were conducted using IBM SPSS version 21.  
Results 
Sample characteristics 
Seventy-six children treated for cerebellar tumors were referred to the study center. Of these, 72 
(95%), comprising 37 with medulloblastoma and 35 with astrocytoma, were enrolled over a 20 
month period of which FSIQ data obtained at the first assessment were available in 32 and 34 
children in the respective groups. The annual rate of enrolment into the study over the 1.8-year 
recruitment period was 104% for medulloblastoma and 87% for astrocytoma of the expected 
number of diagnoses of eligible cases at participating centers over that time, estimated from the 
relevant figures for disease incidence and time trends in the UK population.15 Of the 38 
participants in the non-tumor group, 25 were the first random choice, and seven were the second 
random choice, the first family having declined to participate. FSIQ data obtained at the first 
assessment were available in all of these. In the present study the 66 children treated for 
cerebellar tumors had a mean (range) time interval from tumor diagnosis of 16.3 (1-35) months 
(Table 1). Child and parent demographic characteristics were similar in the two tumor groups 
and the non-tumor group at recruitment excepting an excess of lone parents, only children, lower 
parental educational qualifications, and occupations other than managerial or professional in 
families of children treated for medulloblastoma (Table 1). Mean scores for each measure 
showed poorer functioning in the tumor groups compared with the non-tumor group (Table 2).  
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Screening accuracy of each measure  
Thirteen (41%) of those with medulloblastoma and 6 (18%) of those with cerebellar astrocytoma 
had a FSIQ<80, compared to 1 (3%) in the non-tumor group (Tables 3 and Appendix Table e1). 
Among the 18 children treated for cerebellar tumours that had FSIQ<80, and for whom we had 
information about special education services, 3 (17%) were not attending school regularly, 3 
(17%) were receiving no extra help, 5 (28%) were receiving help commensurate with their class 
mates, typically with reading and mathematics, and 7 (39%) were receiving specific individual 
help. Evaluation of the suitability of all seven questionnaires as a screen for FSIQ<80 
demonstrated that they performed significantly better than chance to detect that condition 
(p<.001) and with moderate accuracy, indicated by AUCs that ranged between 0.73 and 0.85 
(sensitivities ranging from 0.55 to 0.84, specificities ranging from 0.71 to 0.87; and LR+ values 
ranging from 2.74 to 4.90) (Table 4). The 95% CI of four of the seven questionnaires fell entirely 
within the high to moderate accuracy range. These were the child- and parent-report PedsQL and 
the teacher-report BRIEF and SDQ (Table 4).  
 Youden’s index identified the optimum screen threshold score. Child-report PedsQL had 
the greatest AUC (score <65=positive screen, sensitivity 0.84, specificity 0.79, and LR+ of 3.93). 
Parent-report PedsQL (score <51=positive screen, sensitivity 0.65, specificity 0.87, LR+ 4.90), 
teacher-report BRIEF (score >59=positive screen, sensitivity 0.79, specificity 0.77, LR+ 3.46), 
and SDQ (score >7=positive screen, sensitivity 0.84, specificity 0.71) had AUCs that were 
slightly lower but with 95% CIs that overlapped with that of the AUC for child-report PedsQL 
(Figure 1; Table 4).  
Screening by using a score beyond the threshold value on either the teacher-report SDQ 
(sensitivity 0.84, specificity 0.71) or the self-report PedsQL (sensitivity 0.84, specificity 0.79) 
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increased sensitivity (95% CI) to cases of FSIQ<80 to 1.00 (0.79-1.00) (Appendix Table e1) but 
reduced specificity (95% CI) from the above figures to 0.65 (0.53-0.75) (figures not tabulated). 
Discussion 
All screening measures correctly identified 55-84% of children with borderline or greater deficit 
in FSIQ and correctly identified 71-87% of children without a deficit. The precision of these 
estimates was sufficient to indicate that the child- and parent-report PedsQL and the teacher-
report BRIEF and SDQ were moderately or highly accurate screens. Screening positive on any 
one of the child-report PedsQL or the teacher-report SDQ correctly identified all cases with 
FSIQ<80 but decreased the specificity of the screen.   
Our findings are likely to be generalizable to the great majority of children with 
cerebellar tumors for two reasons. First, we included the two most common tumor types and the 
two most common combinations of treatment modalities, namely surgery alone and surgery 
combined with both cranio-spinal radiation therapy and chemotherapy. Second, the population 
base, comprised of the catchment area populations of half (11 of 22) of all UK CCTCs, was large 
and the number of children in the tumor groups that were enrolled was close to the total number 
of cases predicted, from UK national figures for incidence and time trends, to present over the 20 
month recruitment period.44  
The inclusion of an unbiased sample of children of the same age in the general population 
but without tumors enabled us to increase the sample size and therefore the precision of our 
estimates of accuracy as indicated by likelihood ratios and similar measures of accuracy that are 
independent of the population prevalence of the target condition unlike predictive values which 
are prevalence dependent.43,45  
The use of the WISC as a gold standard measure of cognitive function is a strength of this 
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study and the choice of threshold of FSIQ<80, below which 9% of a typically developing 
population and 29% of our sample of children treated for cerebellar tumors falls, is a reasonable 
pragmatic decision, especially when resources only allow direct assessment of a minority of 
cases.  
The added benefit of the three questionnaires that we used is that they also provide a 
screen for problems with executive function, behavioral and emotional problems, and HRQoL 
and their constituent domains of functioning which is another strength of the approach described 
in the present study as it thus avoids focusing too narrowly on those who display low IQ. In fact 
two of these three measures are included in the short battery of assessments devised and shown 
to be deliverable in the setting of a USA Children’s Oncology Group trial.22 The PedsQL has 
been shown to have an impact on clinical intervention decision making in pediatric clinic settings 
for children with rheumatology, cardiology, and orthopedic problems.27 An et al. (2013)29 
reported strong correlations between child-report PedsQL and FSIQ in children aged between 6 
and 13 years treated for brain tumors. This is supported by the present study.   
 Conversely, one potential limitation of a screening approach is its reduction of cognitive 
ability to any single number and the accompanying narrowing of the scope of the cognitive 
deficits to which it is sensitive. This is to some extent unavoidable in the quest for a simple short 
screening test which requires definition of a unitary ‘target condition’. Many survivors of CNS 
tumors have problems with specific skills like attention and processing speed that will 
significantly impair their academic performance without leading to a decrease in their FSIQ to 
less than 808 and, if access to a clinical psychologist can be obtained routinely, a full 
psychological evaluation, including tests of attention, processing speed, working memory, and 
executive function4,7,8,46,47 is preferable to any single screening test. When, on the other hand, it 
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is not possible for the child to gain access to a psychometric assessment, some cases in which 
there are specific cognitive deficits in which the BRIEF score was not sufficiently abnormal to 
constitute a positive screen for FSIQ<80, would nevertheless come to light by closer examination 
of BRIEF scores and sub-scores by a psychologist who has the knowledge and training to 
interpret BRIEF profiles. For these reasons, the screening approach that we propose does not 
oversimplify problems into a binary ‘Yes/No’ decision separated by a dividing line at FSIQ=80 
but permits consideration of the executive, emotional, physical and psychosocial aspects that 
impinge on cognitive function. Examination of subscale scores might be seen as defeating the 
purpose of screening that needs to divide those screened into screen positive and screen negative 
groups but future work could examine the incorporation into the screening process of simple 
reports, based on automated on-line scoring, in which subscale scores that identify 
neurocognitive dysfunction evident before FSIQ scores are affected (e.g., processing speed, 
working memory) could be categorized by scoring centile as green, amber, or red. 
 A second limitation of our study, designed primarily to assess HRQoL in children old 
enough to provide reliable self-report and young enough to remain within the pediatric age range 
after 24 months of follow-up, was the fact that the age range was restricted to 8 to 14 years. Our 
findings may not apply to younger children although children as young as 5 years can reliably 
and validly self-report using the PedsQL.48 Further studies are also needed in children treated for 
tumors in other, particularly supratentorial, locations to examine the performance of these 
screening measures in those contexts.  
 Teacher-report of executive function and behavioral difficulties proved to be an accurate 
source of information about a child’s cognitive and behavioral functioning in our study and was 
relatively strongest in those treated for medulloblastoma,  in whom it correctly identified 85-92% 
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of true cases of FSIQ<80 compared to only 60% of true cases in the astrocytoma group. In 
contrast, parent- and child-report HRQoL correctly identified 83-100% of true cases in the 
astrocytoma group but only 67-75% of cases in the medulloblastoma group. This may indicate 
differences in the variation in screening accuracy of the measures within a clinical context or in 
the sensitivity of teacher-, child-, and parent-report to cognitive deficits or in both. This could be 
explored in future research in a larger sample of children treated for low-grade astrocytoma as 
this group contained few cases of FSIQ<80 in the present study.  
 Our finding that accuracy of 100% was obtainable by accepting a score beyond the 
threshold value for either the self-report PedsQL or the teacher-report SDQ was adopted as a 
strategy post hoc and in future research this needs to be tested in an independent sample. If high 
accuracy were confirmed, the use of teacher-reports as an approach to screening would only 
succeed in an educational context in which teachers are willing to provide their responses to 
health providers. Such success in liaising with teachers would itself constitute an important step 
towards aligning clinical and educational perspectives on the child’s needs.  
It is important to stress that we would recommend repeated annual screening through the 
acute phase of survival into the longer-term during the school years for the detection of cognitive 
deficits as problems emerge over time.29,41 Participants in the present study were all less than 
three years from diagnosis at enrolment and both tumor groups in fact showed an increase in 
their group mean FSIQ over the 24 months for which they remained in the study15 but it is well 
established that a failure to acquire new skills may lead to a fall in FSIQ over time in children 
treated with cranial radiotherapy8 as well as those treated with neurosurgery alone,46 with some 
problems not fully manifested until more than 5 years from diagnosis.4 It is possible that the 
screening battery used here may be sensitive to neuropsychological difficulties related to medical 
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factors known to affect cognitive processes more acutely in the peri-operative period (e.g. 
complications of treatment of hydrocephalus, peri-operative infections or hemorrhage) rather 
than those that emerge over time. Nonetheless, 85% of the sample had been diagnosed more than 
six months previously and were therefore well out of the peri-operative period.   
 In clinical settings where access to pediatric neuropsychologists is readily available, we 
support the use of a short battery such as those proposed by Embry et al.22 in the USA or by 
Ottensmeier et al. (2014)49 in Germany and have made recommendations, together with 
colleagues from 10 other countries across Europe, on the domains and assessments of those 
domains that should be prioritized for assessing survivors of childhood brain tumors.39 These 
psychometric assessments are, however, often not available outside Europe and North America 
or in some countries within Europe, even in the context of treatment trials and are not undertaken 
in most children treated in any country outside the setting of a clinical trial (e.g. many children 
with low grade cerebellar astrocytomas). By contrast, the application of questionnaires has been 
achieved across several European countries in a treatment trial for medulloblastoma,37 is being 
achieved with web-based versions of the questionnaires in a European treatment trial currently 
and is potentially applicable over a wider geographical area and clinical context. The present 
study suggests that where access to psychometric assessment is limited, questionnaires may also 
provide a pragmatic screen to prioritize direct psychometric assessment of those most likely to 
have cognitive deficits in FSIQ and therefore very likely to be in need of support to ameliorate 
these difficulties.  
 The fact that only 39% of the children treated for cerebellar tumours that had a FSIQ<80 
had been identified as having specific educational needs at school, reflects the lack of experience 
of schools in meeting the needs of the relatively rare child with newly acquired, rather than 
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developmental, cognitive deficits and suggests that screening of children for low FSIQ by those 
delivering their health care could help to alert schools to the need for assessment for individual 
special educational needs. These survivors may actually be most in need of neuropsychological 
follow-up in order to characterize their developing pattern of difficulties, and to initiate treatment 
or services before the problems worsen and cause greater functional impairment. The extent to 
which this applies to countries other than the UK merits further study.  
In summary the child- and parent-report PedsQL and the teacher-report BRIEF and SDQ 
have moderately good discriminative power to differentiate children with and without a FSIQ<80 
including 79-84% sensitivity to FSIQ<80. The PedsQL could be used in a clinical setting and the 
BRIEF and SDQ in an educational setting to detect cognitive deficits as well as problems with 
emotional and behavioral disorders, executive dysfunction and poor HRQoL in children treated 
for a brain tumor and indicate the need for referral for a fuller psychological evaluation from an 
early stage.  
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Figure Legend  
Figure 1 
ROC curves showing percentages of sensitivity and specificity for the three measures that 
show the highest accuracy in detecting a FSIQ<80  
PedsQL (n=103), Pediatric Quality of Life Inventory;36 BRIEF (n=98), Behavior Rating 
Inventory of Executive Functioning;34 SDQ (n=99), Strengths and Difficulties Questionnaire.35   
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Table 1. Child and parent characteristics by tumor group 
Medulloblastoma 
n=32 
Astrocytoma 
n=34 
Non-tumor 
n=38 
Mean age in years (range) 10.2 (8-14) 10.4 (8-14) 10.4 (8-14) 
Mean age in years at diagnosis (range) 8.8 (6-13) 9.2 (5-14) N/A 
Mean months from diagnosis (range) 17.6 (1-35) 15.0 (1-35) N/A 
Parent mean age in years (SD) 38.7 (5.1) 40.8 (8.2) 40.5 (5.3) 
n (%) n (%) n (%) 
Female 13 (41) 23 (68) 19 (50) 
Mother  respondent 31 (97) 31 (91) 33 (87) 
Lone parent family 6 (19) 3 (9) 5 (13) 
Only child 6 (19) 3 (9) 4 (11) 
Parent education:    None 
School 
College 
University 
Unknown 
1 (3) 
12 (38) 
14 (44) 
4 (13) 
1 (3) 
2 (6) 
5 (15) 
18 (53) 
9 (27) 
0 
2 (5) 
7 (18) 
21 (55) 
8 (21) 
0 
SES pre-diagnosis: Managerial/Professional 
Intermediate 
Routine & Manual 
Not working 
Unknown 
9 (28) 
12 (38) 
7 (22) 
3 (9) 
1 (3) 
21 (62) 
8 (24) 
5 (15) 
0 
0 
18 (47) 
7 (18) 
10 (26) 
3 (8) 
0 
N/A, not applicable; SD, standard deviation; SES, socio-economic status. 
Table
 Table 2. Mean (SD) scores for each screening measure by tumor group 
Measure  Medulloblastoma 
n=32* 
Astrocytoma 
n=34* 
Non-tumor 
n=38* 
†BRIEF (T score mean=50, SD=10)               
 Parent 55.3 (12.5) 56.3 (11.4) 51.2 (10.0) 
 Teacher 60.1 (13.2) 56.9 (14.4) 51.0 (9.0) 
†SDQ (possible range 0-40)    
 Parent 10.7 (6.7) 10.0 (6.0) 8.1 (5.3) 
 Child 9.7 (4.8) 10.0 (5.8) 8.8 (5.5) 
 Teacher 9.0 (5.2) 6.2 (5.1) 4.7 (5.0) 
‡PedsQL (possible range 0-100)     
 Parent 51.5 (20.8) 68.2 (23.9) 84.3 (11.0) 
 Child 61.2 (18.2) 71.3 (20.4) 82.1 (12.3) 
 
BRIEF, Behavior Rating Inventory of Executive Functioning;34 SDQ, Strengths and Difficulties Questionnaire;35 PedsQL, Pediatric 
Quality of Life Inventory;36 FSIQ, full scale IQ; SD, standard deviation  
*: numbers varied slightly for each measure and informant; higher scores,  
†: higher scores indicate increased dysfunction  
‡: higher scores indicated better quality of life  
  
 
 
 
 
 
 
 
Table
 Table 3. Screening for cognitive deficit following medulloblastoma, low grade cerebellar astrocytoma and 
in a non-tumor comparison group: performance of three self- and proxy-report questionnaires. 
  Target condition of WISC FSIQ<80 present (+) or absent (-) 
                                   
Medulloblastoma Astrocytoma Non-tumor 
  
+ - + - + - 
                                   
n (%)  n (%)  n (%) n (%)  n (%)  n (%) 
FSIQ<80 n (%) 13 (41) 19 (59) 6 (18) 28 (82) 1 (3) 37 (97) 
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BRIEF  
 
Parent (>57) 
+ 8 (62) 4 (21) 6 (100) 10 (36) 1 (100) 7 (19) 
- 5 (38) 15 (79) 0 18 (64) 0 30 (81) 
Teacher (>59) 
+ 11 (85) 3‡ (19) 3* (60) 8* (30) 1 (100) 7* (19) 
- 2 (15) 13‡ (81) 2* (40) 19* (70) 0 29* (81) 
 
SDQ 
 
Child (>11) 
+ 9* (75) 4 (21) 3 (50) 10 (36) 1 (100) 7 (19) 
- 3* (25) 15 (79) 3 (50) 18 (64) 0 30 (81) 
Parent (>14) 
+ 6 (46) 3 (16) 5 (83) 4 (14) 1 (100) 4 (11) 
- 7 (54) 16 (84) 1 (17) 24 (86) 0 33 (89) 
Teacher (>7) 
+ 12 (92) 6† (35) 3* (60) 8* (30) 1 (100) 6* (17) 
- 1 (8) 11† (65) 2* (40) 19* (70) 0 30* (83) 
 
PedsQL 
 
Child (<65) 
+ 9* (75) 9 (47) 6 (100) 6 (21) 1 (100) 3 (8) 
- 3* (25) 10 (53) 0 22 (79) 0 34 (92) 
Parent (<51) 
+ 8 (62) 9* (50) 5 (83) 2 (7) 0 0 
- 5 (38) 9* (50) 1 (17) 26 (93) 1 (100) 37 (100) 
 
BRIEF, Behavior Rating Inventory of Executive Functioning;34 SDQ, Strengths and Difficulties Questionnaire;35 PedsQL, Pediatric 
Quality of Life Inventory;36 FSIQ, full scale IQ 
*: 1 missing value 
†: 2 missing values 
‡: 3 missing values
 
Table
Table 4. Screening accuracy to detect a FSIQ<80 based on maximum Youden’s Index for each measure 
Measure N Informant Cut-off score AUC (95% CI)  Sens% (95% CI) Spec% (95% CI) LR+ LR- J 
BRIEF* 
104 Parent >57 .76 (.61 to .90)  75 (51 to 90) 75 (64 to 84) 3.00 0.33 0.50 
98 Teacher >59 .82 (.70 to .94) 79 (54 to 93) 77 (66 to 86) 3.46 0.27 0.56 
SDQ* 
103 Child >11 .73 (.63 to .84) 68 (43 to 86) 75 (64 to 84) 2.74 0.42 0.43 
104 Parent >14 .78 (.67 to .89) 55 (36 to 80) 87 (77 to 93) 4.20 0.52 0.42 
99 Teacher >7 .80 (.70 to .94) 84 (60 to 96) 71 (64 to 84) 2.93 0.22 0.56 
PedsQL† 
103 Child <65 .85 (.77 to .93) 84 (60 to 96) 79 (68 to 86) 3.93 0.20 0.63 
103 Parent <51 .82 (.72 to .92) 65 (41 to 84) 87 (77 to 93) 4.90 0.40 0.52 
BRIEF, Behavior Rating Inventory of Executive Functioning;34 SDQ, Strengths and Difficulties Questionnaire;35 PedsQL, Pediatric Quality of Life Inventory;36 AUC, area under 
the curve; Sens, sensitivity; Spec, specificity; LR+, likelihood ratio for a positive test; LR-,  likelihood ratio for a negative test; J, Youden Index. All AUCs were significant at 
p<001.  
*: higher scores indicate increased dysfunction  
†: higher scores indicate better quality of life  
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Figure
Appendix Table 1. Sensitivity of selected screens for detection of 20 cases of full scale IQ score <80 from a 
population of 8-14 year old children with and without preceding cerebellar tumors. 
Screening questionnaires 
Patient ID Teacher BRIEF 
cut-off score >59 
Teacher SDQ 
cut-off score >7 
Parent PedsQL 
cut-off score <51 
Child PedsQL 
cut-off score <65 
Medulloblastoma  105 + + - missing 
  107 + + + + 
  109 + + + + 
  113 + + + + 
  115 + + + + 
  118 + + - + 
  120 + + + + 
  126 + + - - 
  127 + + + + 
  130 + + + + 
  131 - + - - 
  136 + + + + 
  138 - - - - 
Total +ve 11 12 8 9 
Astrocytoma  203 + + + + 
  212 - - + + 
  229 - - + + 
  233 missing missing + + 
  232 + + + + 
  235 + + - + 
Total +ve 3 3 5 6 
Non-tumor  307 + + - + 
Total +ve 1 1 0 1 
Grand Total +ve 16 16 13 16 
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BRIEF, Behavior Rating Inventory of Executive Functioning;34 SDQ, Strengths and Difficulties Questionnaire;35 PedsQL, Pediatric 
Quality of Life Inventory;36 FSIQ, full scale IQ; SD, standard deviation; +, screen positive; -, screen negative; +ve, positive 
